Suppr超能文献

人和大鼠肝脏及胎盘中碘甲状腺原氨酸硫酸酯酶活性的表征

Characterization of iodothyronine sulfatase activities in human and rat liver and placenta.

作者信息

Kester Monique H A, Kaptein Ellen, Van Dijk Caren H, Roest Thirza J, Tibboel Dick, Coughtrie Michael W H, Visser Theo J

机构信息

Department of Internal Medicine, Erasmus University Medical School, 3000 DR Rotterdam, The Netherlands.

出版信息

Endocrinology. 2002 Mar;143(3):814-9. doi: 10.1210/endo.143.3.8686.

Abstract

In conditions associated with high serum iodothyronine sulfate concentrations, e.g. during fetal development, desulfation of these conjugates may be important in the regulation of thyroid hormone homeostasis. However, little is known about which sulfatases are involved in this process. Therefore, we investigated the hydrolysis of iodothyronine sulfates by homogenates of V79 cells expressing the human arylsulfatases A (ARSA), B (ARSB), or C (ARSC; steroid sulfatase), as well as tissue fractions of human and rat liver and placenta. We found that only the microsomal fraction from liver and placenta hydrolyzed iodothyronine sulfates. Among the recombinant enzymes only the endoplasmic reticulum-associated ARSC showed activity toward iodothyronine sulfates; the soluble lysosomal ARSA and ARSB were inactive. Recombinant ARSC as well as human placenta microsomes hydrolyzed iodothyronine sulfates with a substrate preference for 3,3'-diiodothyronine sulfate (3,3'-T(2)S) approximately T(3) sulfate (T(3)S) >> rT(3)S approximately T(4)S, whereas human and rat liver microsomes showed a preference for 3,3'-T(2)S > T(3)S >> rT(3)S approximately T(4)S. ARSC and the tissue microsomal sulfatases were all characterized by high apparent K(m) values (>50 microM) for 3,3'-T(2)S and T(3)S. Iodothyronine sulfatase activity determined using 3,3'-T(2)S as a substrate was much higher in human liver microsomes than in human placenta microsomes, although ARSC is expressed at higher levels in human placenta than in human liver. The ratio of estrone sulfate to T(2)S hydrolysis in human liver microsomes (0.2) differed largely from that in ARSC homogenate (80) and human placenta microsomes (150). These results suggest that ARSC accounts for the relatively low iodothyronine sulfatase activity of human placenta, and that additional arylsulfatase(s) contributes to the high iodothyronine sulfatase activity in human liver. Further research is needed to identify these iodothyronine sulfatases, and to study the physiological importance of the reversible sulfation of iodothyronines in thyroid hormone metabolism.

摘要

在与高血清硫酸碘甲腺原氨酸浓度相关的情况下,例如在胎儿发育期间,这些结合物的去硫酸化在甲状腺激素稳态调节中可能很重要。然而,对于参与这一过程的硫酸酯酶知之甚少。因此,我们研究了表达人芳基硫酸酯酶A(ARSA)、B(ARSB)或C(ARSC;类固醇硫酸酯酶)的V79细胞匀浆以及人和大鼠肝脏及胎盘的组织部分对硫酸碘甲腺原氨酸的水解作用。我们发现,只有肝脏和胎盘的微粒体部分能水解硫酸碘甲腺原氨酸。在重组酶中,只有内质网相关的ARSC对硫酸碘甲腺原氨酸有活性;可溶性溶酶体的ARSA和ARSB无活性。重组ARSC以及人胎盘微粒体水解硫酸碘甲腺原氨酸时,对底物的偏好为3,3'-二碘甲腺原氨酸硫酸盐(3,3'-T(2)S)约等于T(3)硫酸盐(T(3)S) >> 反T(3)硫酸盐(rT(3)S)约等于T(4)S,而人和大鼠肝脏微粒体则偏好3,3'-T(2)S > T(3)S >> rT(3)S约等于T(4)S。ARSC和组织微粒体硫酸酯酶对3,3'-T(2)S和T(3)S的表观K(m)值都很高(>50 microM)。以3,3'-T(2)S为底物测定的碘甲腺原氨酸硫酸酯酶活性在人肝脏微粒体中比在人胎盘微粒体中高得多,尽管ARSC在人胎盘中的表达水平高于人肝脏。人肝脏微粒体中硫酸雌酮与T(2)S水解的比率(0.2)与ARSC匀浆(80)和人胎盘微粒体(150)中的比率有很大差异。这些结果表明,ARSC是造成人胎盘碘甲腺原氨酸硫酸酯酶活性相对较低的原因,而其他芳基硫酸酯酶对人肝脏中高碘甲腺原氨酸硫酸酯酶活性有贡献。需要进一步研究来鉴定这些碘甲腺原氨酸硫酸酯酶,并研究碘甲腺原氨酸可逆硫酸化在甲状腺激素代谢中的生理重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验